TrialJournal of cancer research and clinical oncology2021

Greater treatment satisfaction in patients receiving daratumumab subcutaneous vs. intravenous for relapsed or refractory multiple myeloma: COLUMBA clinical trial results.

Saad Z Usmani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.